Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine with or without azithromycin for COVID-19 infection
2020-001606-33Phase 3Terminated
- Sponsor
- Biocruces Bizkaia Health Research Institute
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine monotherapy with Hydroxychloroquine + azithromycin (2 arms). Primary endpoint: Proportion of patients with negative SARS-CoV-2 PCR at day 6. Started Apr 2020; status: terminated.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001606-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001606-33.